tirzepatide fda shortage list The Outsourcing Facilities Association (OFA) is suing the after the agency removed (Zepbound, Mounjaro) from the federal drug without proper notice. The lawsuit claims that the FDA failed Important Announcement FDA Update on

At least one treatment-emergent nervous system disorder adverse event occurred in 15.8% of the tirzepatide group and 13% of the placebo group

The TESTING randomized controlled clinical trial consisted of 503 patients randomized with 257 in the treatment group and 246 in the placebo group

2023;40 doi: 10.1111/dme.15230

The industry is actively seeking differentiated small molecule oral drugs that can overcome the limitations of current options

Combining phentermine and semaglutide is a topic of growing interest, though the combination is off-label and requires careful medical supervision

Most of my patients have minimal or no nausea